124
Participants
Start Date
October 15, 2021
Primary Completion Date
July 23, 2023
Study Completion Date
July 23, 2023
BNT162b2
Intramuscular Injection
Charite - Universitaetsmedizin Berlin - Campus Virchow-Klinikum (CVK), Berlin
Charité - Universitaetsmedizin, Berlin
Charité Campus Virchow-Klinikum, Berlin
Universitätsklinikum Hamburg-Eppendorf, Hamburg
Cincinnati Children's Hospital Medical Center, Cincinnati
Cincinnati Children's Hospital Medical Center, Cincinnati
Cincinnati Children's Hospital Vaccine Research Center, Cincinnati
Cincinnati Children's Hospital, Cincinnati
Henry Ford Health System, Detroit
Henry Ford Hospital - Research Pharmacy, Detroit
IKF Pneumologie GmbH & Co KG, Frankfurt am Main
"Hospital Universitario Dr. Jose Eleuterio Gonzalez de la Universidad Autonoma de Nuevo Leon", Monterrey
Centro Médico Zambrano Hellion, San Pedro Garza García
Ochsner Clinic Foundation, Kenner
Ochsner Medical Center Kenner, Kenner
Ochsner Clinic Foundation, Jefferson
Ochsner Medical Center - Jefferson Highway, Jefferson
Ochsner Clinic Foundation, New Orleans
Ochsner Medical Center - Jefferson Highway, New Orleans
Texas Children's Hospital, Houston
Seattle Children's Research Institute: Building Cure, Seattle
Seattle Children's Hospital, Seattle
Hospital de Clinicas de Porto Alegre, Porto Alegre
Hospital de Clinicas de Porto Alegre, Porto Alegre
Fundação Faculdade Regional de Medicina de São José do Rio Preto, São José do Rio Preto
GRAACC - Grupo de Apoio ao Adolescente e à Criança com Câncer, São Paulo
CEPIC - Centro Paulista de Investigação Clínica, São Paulo
Studiengesellschaft BSF UG., Halle
Studiengesellschaft BSF Unternehmergesellschaft, Halle
Lead Sponsor
Collaborators (1)
Pfizer
INDUSTRY
BioNTech SE
INDUSTRY